A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor-Reference-Cited by-同舟云学术

A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor

Published:2014-01 Issue:1 Volume:89 Page:83-87
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Devillier Raynier¹²³,Fürst Sabine¹,Crocchiolo Roberto¹,El-Cheikh Jean¹,Castagna Luca¹⁴,Harbi Samia¹,Granata Angela¹,D'Incan Evelyne¹,Coso Diane¹,Chabannon Christian²³⁵⁶,Picard Christophe⁷,Etienne Anne¹,Calmels Boris⁵⁶,Schiano Jean-Marc¹,Lemarie Claude⁵⁶,Stoppa Anne-Marie¹,Bouabdallah Reda¹,Vey Norbert¹²³,Blaise Didier¹²³

Affiliation:

1. Département d'Onco-Hématologie; Institut Paoli-Calmettes, Unité de Transplantation et de Thérapie Cellulaire; F-13273 Marseille France

2. Aix-Marseille Université; F-13007 Marseille France

3. Inserm UMR1068, Centre de Recherche en Cancérologie de Marseille (CRCM); F-13009 Marseille France

4. Humanitas Cancer Center, Hematology Unit; Instituto Clinico Humanitas; Rozzano Milano Italy

5. Institut Paoli-Calmettes, Centre de Thérapie Cellulaire (Cell Therapy Facility); F-13273 Marseille France

6. Inserm CBT-510, Centre d'Investigations Cliniques en Biothérapie; F-13009 Marseille France

7. Laboratory of Histocompatibility; EFS Alpes Mediterrannée; Marseille France

Publisher

Wiley

Subject

Hematology

Reference23 articles.

1. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: A prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy;Yakoub-Agha;J Clin Oncol,2006

2. Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A;Schlenk;J Clin Oncol,2010

3. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation;Lee;Blood,2007

4. Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia;Saber;Blood,2012

5. Do different conditioning regimens really make a difference?;Blaise;Hematology Am Soc Hematol Educ Program,2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Benefits of the Post-Transplant Cyclophosphamide in Both Haploidentical and Mismatched Unrelated Donor Setting in Allogeneic Stem Cells Transplantation;International Journal of Molecular Sciences;2023-03-17

2. Am I Dreaming?;Patients’ Lived Experiences During the Transplant and Cellular Therapy Journey;2023

3. Feasibility of Cyclosporine Prophylaxis Withdrawal in Critically Ill Allogenic Hematopoietic Stem Cell Transplant Patients Admitted to the Intensive Care Unit With No GVHD;Transplantation and Cellular Therapy;2022-11

4. Post-transplant cyclophosphamide versus antithymocyte globulin as GVHD prophylaxis for 10/10 HLA-matched unrelated allogeneic hematopoietic stem cell transplantation.;2022-09-27

5. Posaconazole bioavailability of the solid oral tablet is reduced during severe intestinal mucositis;Clinical Microbiology and Infection;2022-07